caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1528205770

Daniel RoweM.D.

PRACTICEUMMHCSee all providers at this practice →
PsychiatryWorcester, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
565
Beneficiaries
—
Total drug cost
$16K
Distinct drugs
25
Brand share
17.2%
Top prescribed drugs
Clonazepam63 claims
Mirtazapine50 claims
Trazodone Hcl42 claims
Escitalopram Oxalate39 claims
Lorazepam28 claims
REFERRAL NETWORK

Where Daniel Rowe's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Cezar Cimpeanu
Psychiatry · Worcester, MA
1878
Anil Varma Vatsavayi
Psychiatry · Worcester, MA
1582
Negar Beheshti
Psychiatry · Webster, MA
1372
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
177
Unique beneficiaries
—
Total services
452
Distinct HCPCS
5
Medicare payment
$38K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,006 Psychiatry providers in MA — above median (cohort median 248).